ABL1 and melanoma: Importantly, ABL1 and MYC mRNAs are correlated in melanomas from patients prior to treatment (Fig. 6b, left) and in the TCGA dataset (Supplementary Fig. 5c), and an even more significant correlation was observed in paired samples from the same patients following relapse on BRAFi or BRAFi/MEKi (Fig. 6b, right).